References
- Rubin R. L. Antihistone antibodies. Systemic Lupus Erythematosus, 2nd Edition, R. G. Lahita. Churchill Livingstone. 1992; 247–271
- Fritzler M. J., Rubin R. L. Drug-induced lupus. Dubois' Lupus Erythematosus, 4th Edition, D. J. Wallace, B. H. Hahn. Lea & Febiger, Philadelphia 1993; 442–453
- Klajman A., Kafri B., Shohat T., Drucker I., Moalem T., Jaretzky A. The prevalence of antibodies to histones induced by procainamide in old people, in cancer patients, and in rheumatoid-like diseases. Clin. Immunol. Immunopathol. 1983; 27: 1–8
- Blomgren S. E., Condemi J. J., Bignall M. C., Vaughan J. H. Antinuclear antibody induced by procainamide: A prospective study. N. Engl. J. Med. 1969; 281: 64–66
- Ayer L M., Rubin R. L., Dixon G. H., Fritzler M. J. Antibodies from patients with drug-induced autoimmunity react with high mobility group (HMG) proteins. Arthritis Rheum 1994; 37: 98–103
- Burlingame R. W., Rubin R. L. Drug-induced antihistone autoantibodies display two patterns of reactivity with substructures of chromatin. J. Clin. Invest. 1991; 88: 680–690
- Granja C. D.B., Santiago M. B., Viana V. S.T., et al. Caracterizacao clinico-laboratorial de auto-anticorpos induzidos por isoniazida. Rev. Paul. Med. 1990; 108: 57–60
- Siegel M., Lee S. L., Peress N. S. The epidemiology of drug-induced systemic lupus erythematosus. Arthritis Rheum 1967; 10: 407–715
- Price-Evans D. A., Bullen M. F., Houston J., Hopkins C. A., Vetters J. M. Antinuclear factors in rapid and slow acetylator patients treated with isoniazid. J. Med. Genet. 1972; 9: 53–56
- Cannat A., Seligmann M. Possible induction of antinuclear antibodies by isoniazid. Lancet 1966; 1: 185–187
- Alarcon-Segovia D., Fishbein E., Betancourt V. M. Antibodies to nucleo-protein and to hydrazide-altered soluble nucleoprotein in tuberculous patients receiving isoniazid. Clin. Exp. Immunol. 1969; 5: 429–437
- Lindqvist K. J., Coleman R. E., Osterland C. K. Autoantibodies in chronic pulmonary tuberculosis. J. Chron. Dis. 1970; 22: 717–725
- Alarcon-Segovia D., Fishbein E. Serum immunoglobulins in pulmonary tuberculosis. Chest 1971; 60: 133–136
- Dhand R., Gilhotra R., Sehgal S., et al. Incidence of isoniazid-induced antinuclear antibodies in patients of tuberculosis. Indian J. Med. Res. 1987; 85: 503–507
- Rothfield N. F., Bierer W. F., Garfield J. W. Isoniazid induction of anti-nuclear antibodies. A prospective study. Ann. Intern. Med. 1978; 88: 650–652
- Igo-Kemenes T., Horz W., Zachau H. G. Chromatin. Ann. Rev. Biochem. 1982; 51: 89–121
- Rubin R. L. Enzyme-linked immunosorbent assay for anti-DNA and anti-histone antibodies including anti-(H2A-H2B). Manual of Clinical Laboratory Immunology, 4th Edition, N. R. Rose, E. C. de Macario, J. L. Fahey, H Friedman, G. M. Penn. ASM, Washington, D.C. 1992; 735–740
- Burlingame R. W., Rubin R. L. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J. Immunol. Methods 1990; 134: 187–199
- Rubin R. L., Burlingame R. W., Arnott J. E., Totoritis M. C., McNally E. M. and Johnson A.D. IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus. J. Immunol. 1995; 154: 2483–2493
- Rubin R. L., Bell S. A., Burlingame R. W. Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J. Clin. Invest. 1992; 90: 165–173
- Salazar-Paramo M., Rubin R. L., Garcia-de la Torre I. Isoniazid-induced systemic lupus erythematosus. Ann. Rheum. Dis. 1992; 51: 1085–1087
- Ten Veen J. H., Feltkamp T. E.W. Studies on drug induced lupus erythematosus in mice. I. Drug induced antinuclear antibodies (ANA). Clin. Exp. Immunol. 1972; 11: 265–276
- Muller S., Barakat S., Watts R., Joubaud P., Isenberg D. Longitudinal analysis of antibodies to histones, Sm-D peptides and ubiquitin in the serum of patients with systemic lupus erythematosus, rheumatoid arthritis and tuberculosis. Clin. Exp. Rheumatol. 1990; 8: 445–453
- Nilsson B. S., Sultzer B. M., Bullock W. W. Purified protein derivative of tuberculin induces immunoglobulin production in normal mouse spleen cells. J. Exp. Med. 1973; 137: 127–139
- Shoenfeld Y., Isenberg D. A. Mycobacteria and autoimmunity. Immunol. Today 1988; 9: 178–181
- Bonfa E., Llovet R., Scheinberg M., De Souza J. M., Elkon K. B. Comparison between autoantibodies in malaria and leprosy with lupus. Clin. Exp. Immunol. 1987; 70: 529–537
- Al-Tawil N. G., Thewaini A. J. Study of the immunological status of patients with pulmonary tuberculosis. Scand. J. Immunol. 1978; 8: 333–338
- Sela O., El-Roeiy A., Isenberg D. A., et al. A common anti-DNA idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum 1987; 30: 50–56
- Barnes P. F., Lu S., Abrams J. S., Wang E., Yamamura M., Modlin R. L. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 1993; 61: 3482–3489
- O'Mahony S., Ferguson A. Small intestinal mucosal protection mechanisms and their importance in rheumatology. Ann. Rheum. Dis. 1991; 50: 331–336